Endocrine Complications of IO: Pituitary Hormone Profile Should Be Appropriately Monitored for Pts on Anti-CTLA-4, Primary Thyroid Dysfunction Is More Frequently Observed in Anti-PD-1/PDL-1 Therapy

172 views
March 24, 2020
0 Comments
Login to view comments. Click here to Login